HPV

1,913 views

Published on

hpv

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,913
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
25
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

HPV

  1. 1. HPV INFECTION
  2. 2. Human Papilloma Virus (HPV) • DNA virus that infect epithelial cells • More than 100 strains • Persistent and oncogenic* (gene that has potential to cause cancer.) • Most normal cells undergo a programmed form of death (apoptosis). Oncogenes can cause those cells that ought to die to survive and proliferate instead. Most oncogenes require an additional step, such as mutations in another gene, or environmental factors, such as viral infection, to cause cancer. Many cancer drugs target proteins encoded by oncogenes • Infects epithelium of cervix, vagina, vulva, anus, penis, mouth, a nd sinus • ~ 30 strains have the potential to transform epithelial cells into pre-malignant, and ultimately malignant, cells
  3. 3. HPV Infection • The most prevalent sexually- transmitted infection in U.S. with 6.2 million cases; over 20 million worldwide • Most cases stem from infection by the human papillomavirus (HPV)transmitted by unprotected sex • Smoking, immunosuppression, and prolonged use of oral contraceptives may contribute to incidence • HPV infection directly associated with a higher risk of cervical cancer • Cervical cancer is usually detected through the Pap smear • Most infections are self-limited and disappear
  4. 4. 4 Human Papillomavirus (HPV) Hill Companie s. All Rights Reserved • Diagnosis and treatment • Diagnosed based on the appearance of lesions • Often detected during routine PAP tests • Special tests can detect HPV and distinguish among the more common strains, including those that cause most cases of cervical cancer • Treatment focuses on reducing the number and size of warts • Cryosurgery (freezing) • Electrocautery (burning) • Laser surgery • Acid treatments
  5. 5. Cervical cancer • Over 500,000 cases diagnosed annually worldwide with 260,00 deaths;in the US, 9,710 cases and 3,700 deaths • Cervical cancer is 2nd leading cause of death among women worldwide • Most common in women in their 20’s and 30’s 5
  6. 6. HPV Infection • Evades immune system destruction by: - Downregulating cellular immune response - No release of inflammatory cytokines - Poor response of antibody • End result is establishment of a persistent asymptomatic infection that may lead to pre-malignant cellular reactions
  7. 7. Diagnosis of Infection • Usually diagnosed by the detection of an abnormal Pap smear indicating chronic infection • Asymptomatic infection is common; occasionally, genital warts
  8. 8. Cervical Cancer • Prevention of cervical cancer can be accomplished with use of an effective HPV vaccine • PAP test is a highly effective screening test for this cancer • All sexually active women ages 18-65 should be tested regularly
  9. 9. HPV Vaccine • Vaccine effectiveness is 90-95% in most population trials; • Clinical studies involving nearly 10 years of follow-up show that the vaccine efficiacy. • girls who are vaccinated do not exhibit the kinds of cell changes that preceed cervical cancer. • results for nearly 100 % of cases for HPV types vaccine is for. • vaccine has the most effect when it is given to girls who have not had any sexual encounters, • 2 HPV vaccines approved by FDA :Gardasil, Cervarix • Gardasil • Quadrivalent vaccine (mix of 4 )developed by Merck • Protects against 4 types of HPV virus : • Most effective before the onset of sexual activity • vaccine is 93 %effective for girls who are vaccinated at age 10 to 13, whereas effect is about 70 % for young women aged 14-17 • Also prevents 90% of genital warts • Approved for boys and men • Cervarix • Doesn’t protect against genital warts, but may be more effective in protections against cervical cancer
  10. 10. Vaccine admin • recommend vaccine for girls and women ages 9 through 26; ideally, prior to the onset of sexual activity • Administered in 3 doses over 6 months • Cost issues - $360 per 3 dose regimen • Covered by most form of insurance; special programs through Medicaid and SCHIP • Vaccines for other HPV strains in development
  11. 11. Vaccine Acceptability • Evidence suggests high degree of acceptability by physicians, gynecologists, patients, and parents • Issue/concern on the part of some parents that use will increase sexual activity • Issue of mandating vaccine in the states; no state currently has such a statute • A study of nearly a million girls in Sweden and Denmark eradicates showed no serious side effetcs.
  12. 12. Controversy: get girls vaccinated? For or against?

×